These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


503 related items for PubMed ID: 17674672

  • 1. [Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].
    Helldén A, Bergman U, Dwyer R, Medin C, Molanaei H, Ståhle L, Thylén P, Odar-Cederlöf I.
    Lakartidningen; ; 104(24-25):1916-20. PubMed ID: 17674672
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment.
    Helldén A, Lycke J, Vander T, Svensson JO, Odar-Cederlöf I, Ståhle L.
    J Antimicrob Chemother; 2006 May; 57(5):945-9. PubMed ID: 16540518
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
    Lin WR, Lin HH, Lee SS, Tsai HC, Huang CK, Wann SR, Chen YS, Chiang SC, Yen MY, Liu YC.
    J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of alpha-herpes virus infections].
    Honda M.
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():306-10. PubMed ID: 16615489
    [No Abstract] [Full Text] [Related]

  • 8. Valaciclovir: a review of its use in the management of herpes zoster.
    Ormrod D, Goa K.
    Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
    [Abstract] [Full Text] [Related]

  • 9. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J, Hanada K, Katoh N, Katoh S, Sakamoto K, Asai J, Takenaka H, Kishimoto S.
    Dermatology; 2009 Jun; 218(1):60-2. PubMed ID: 18974630
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of valaciclovir dosage reduction in continuous ambulatory peritoneal dialysis patients.
    Stathoulopoulou F, Dhillon S, Thodis H, Stathakis C, Vargemezis V.
    Nephron; 2002 May; 91(1):164-6. PubMed ID: 12021536
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Valacyclovir for the treatment of genital herpes.
    Brantley JS, Hicks L, Sra K, Tyring SK.
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
    Tyring SK, Plunkett S, Scribner AR, Broker RE, Herrod JN, Handke LT, Wise JM, Martin PA, Valomaciclovir Zoster Study Group.
    J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
    [Abstract] [Full Text] [Related]

  • 19. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
    Smiley ML, Murray A, de Miranda P.
    Adv Exp Med Biol; 1996 Aug; 394():33-9. PubMed ID: 8815698
    [No Abstract] [Full Text] [Related]

  • 20. [Neurotoxicity of acyclovir].
    Calvo Romero JM, Barquilla Esteban JF, Arrobas Vacas M.
    Rev Clin Esp; 1997 Apr; 197(4):297. PubMed ID: 9197149
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.